Early sodium bicarbonate therapy for critically ill patients with septic shock and acute moderate metabolic acidosis  

作　　者：Sai Huang Yaojun Peng Xuan Zhang Yuan Yao Cong Feng 

机构地区：[1]Department of Hematology,Fifth Medical Center of Chinese PLA General Hospital,Beijing,China [2]National Clinical Research Center of Geriatric Diseases,Chinese PLA General Hospital,Beijing,China [3]Department of Emergency,First Medical Center of Chinese PLA General Hospital,Beijing,China [4]Hospital Management Institute,Medical innovation research department,Chinese PLA General Hospital,Beijing,China [5]Department of General Medicine,Hainan Hospital of General Hospital of People’s Liberation Army,Beijing,China [6]State Key Laboratory of Kidney Diseases,National Clinical Research Center of Kidney Diseases,General Hospital of People’s Liberation Army,Beijing,China.

出　　处：《Emergency and Critical Care Medicine》2024年第3期101-102,共2页急危重症医学（英文）

基　　金：support from the National Natural Science Fund(no.82072200).

摘　　要：To the editor:In recent decades,septic shock has continued to be a life-threatening health problem around the world.^([1])Meanwhile,metabolic acidosis(MA)is also well known in critically ill patients,and even moderate metabolic acidosis(MMA)is associated with higher mortality than sepsis.^([2])Although the administration of sodium bicarbonate(SB)is widely used in sepsis shock with MA in the intensive care unit(ICU),its clinical efficacy is not well established.In the 2021 update of the Surviving Sepsis Campaign guidelines,Evans et al.

关 键 词：critically EDITOR continued 

分 类 号：R459.7[医药卫生—急诊医学]